PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9140565-9 1997 Prothrombin time, APTT, and fibrinogen concentrations decreased after infusions and vWf:Ag and FVIII:C activities were decreased in dose-dependent manner in HES-treated ponies. Hydroxyethyl Starch Derivatives 157-160 von Willebrand factor Homo sapiens 84-87 19825916-3 2010 RESULTS: Group HES and GEL had significantly prolonged PT and aPTT, decreased VIII:C and vWF immediately after AHFI. Hydroxyethyl Starch Derivatives 15-18 von Willebrand factor Homo sapiens 89-92 18633012-9 2008 In the early postoperative phase, HES 130/0.4 was found to exert significantly less effect on measures of coagulation, especially activated partial thromboplastin time and von Willebrand factor (antigen and ristocetin cofactor), than HES 200/0.5. Hydroxyethyl Starch Derivatives 34-37 von Willebrand factor Homo sapiens 172-193 17122237-10 2006 CONCLUSIONS: Patients with Type O blood may have increased coagulation compromise, and greater dilution of Factor VIII activity, vWF:ag, and vWF:RCof after acute normovolemic hemodilution with HES. Hydroxyethyl Starch Derivatives 193-196 von Willebrand factor Homo sapiens 141-144 11375811-6 2001 The decrease in VIII/vWF complex was proportional to the volume of infused HES (20 and 30 mL/kg) and was more pronounced in patients of the O blood group. Hydroxyethyl Starch Derivatives 75-78 von Willebrand factor Homo sapiens 21-24 1377457-7 1992 The acute phase reaction of factor VIII coagulant and von Willebrand factor, which plays a role in postoperative hypercoagulability, was attenuated by the use of HES. Hydroxyethyl Starch Derivatives 162-165 von Willebrand factor Homo sapiens 54-75